BlackRock's new research paper argues that traditional payment methods like cards and bank transfers are unsuitable for AI agents that transact autonomously. It proposes a two-tier system where stablecoins handle spending due to their fast, machine-friendly settlement, while Bitcoin serves as a store of value. This view is supported by a study showing AI models prefer Bitcoin for saving and stablecoins for spending. The paper highlights the growing volume and scale of stablecoins, positioning them as a natural fit for machine transactions in the evolving AI economy.
BlackRock's view on AI agents and machine-native money provides context for cryptocurrency market activity. For readers following crypto trends, here is Pluang's market snapshot as of Sep 23, 2026 15:41 WIB: Out of 50 major cryptocurrencies priced on Pluang, 40 rose and 9 fell today. Notable moves include BCH (Bitcoin Cash) up 34.39% at Rp6.407.420 with a typical hold time of 68 days and a Pluang order activity of 63% Sell / 37% Buy, ONE (Harmony) down 21.73% at Rp52 with a hold time of 152 days and 54% Sell / 46% Buy order activity, and UNI (Uniswap) up 16.69% at Rp186.335 with a hold time of 65 days and 56% Sell / 44% Buy order activity.
A Snap insider has sold 20,000 shares as the company's stock has declined by 27% over the last year. This insider sale may signal concerns about the stock's near-term prospects or a personal decision to liquidate holdings. Investors should watch for ...
Analyst Daniel Sparks projects Sandisk's stock price to rise from about $1,790 to the low $2,000s by 2030. This growth forecast suggests the stock will not outperform the broader market during this period. Investors should consider this moderate outl...
In September 2026, five monthly dividend stocks popular among Boomer investors demonstrated reliable income streams and growth. Realty Income, Agree Realty, STAG Industrial, Main Street Capital, and Gladstone Investment each either raised or maintain...
PONS crypto rose 11% recently, showing signs of building momentum with a potential 40% gain if it reaches $1. However, the altcoin faces challenges due to a significant drop in the Pons app's daily revenue, falling from $11M to $2M, which funds 80% o...
Cardiol Therapeutics has achieved its original enrollment target of 110 patients early in its Phase III MAVERIC trial for CardiolRx™, a drug aimed at reducing recurrent pericarditis risk. Due to fewer-than-expected recurrences observed in a blinded r...
